期刊文献+

新世纪的临床微生物学 被引量:4

Clinical microbiology in the 21st century
下载PDF
导出
摘要 临床微生物学在过去20年取得了全面发展,但依然面临许多新问题,包括分子生物学诊断的权利受限,缺乏专业人力资源,费用调配,获得实验室资助,如何及时正确鉴定和控制耐药菌株传播及新发和再发的传染病的及时诊断等。分子生物学技术的迅速发展为微生物的检测创造了新的机遇。本文根据美国微生物学院2008年院士学术报告会报道,就新世纪临床微生物学的现状、难题和机遇、急需解决的问题及未来趋势做一评述,并对学科发展提一些建议。 Clinical microbiology has developed greatly in the past 20 years. But it is still confronted with lots of new problems including the limitation to the right of molecular biology diagnosis, lack of professional human resources, handicap of expenses adjustment and challenges for acquiring laboratory support. Besides, there are other challenges about how to timely identify drug-resistant bacteria, control their spread and to diagnose the emerging and re-emerging infectious diseases. However, molecular biology technology has created a new opportunity for microbiological detection. This article gives comments on the current status, problems, opportunities, and trends of clinical microbiology in the 21st century and make suggestions on discipline development according to a report from the American College of Microbiology in 2008.
出处 《传染病信息》 2009年第1期9-13,共5页 Infectious Disease Information
关键词 临床微生物学 现状 未来发展 clinical microbiology current status future development
  • 相关文献

参考文献20

  • 1American college of microbiology. Clinical microbiology in the 21st century: keeping the pace[EB/OL].[2008-12-10]. http://www.asm.org/ASM/files/ccLibraryFiles/Filename/000000003981/Clinical_Microbiology_in_the_21 st_Century.pdf#xml= http://search, asm. org/texis/search/pdfhi.txt?query=Clinical+Microbiology+in+the+21 st+Century%3A+Keeping+the+Pace&pr=ASM+Site&prox=page&rorder=500&rprox=500&rdfreq=500&rwfreq=500&rlead=500&rdepth=0&sufs=0&order=r&mode=&opts=&cq=&id=4833aeed11.
  • 2Thornsberry C, Ogilvie PT, Holley HP Jr, et al. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study[J]. Antimicrob Agents Chemother, 1999,43(11): 2612-2623.
  • 3dos Santos Soares MJ, da Silva-Carvalho MC, Ferreira-Carvalho BT, et al. Spread of methicillin-resistant Staphylococcus aureus belonging to the Brazilian epidemic clone in a general hospital and emergence of heterogenous resistancetoglycopeptide antibiotics among these isolates [J]. J Hosp Infect, 2000,44(4):301-308.
  • 4Muldrew KL, Tang YW, Li H, et al. Clonal dissemination of Staphylococcus epidermidis in an oncology ward [J]. J Clin Microbiol, 2008,46(10):3391-3396.
  • 5Tenover FC, McDonald LC. Vancomycin-resistant staphylococci and enterococci: epidemiology and control [J]. Curr Opin Infect Dis, 2005,18(4):300-305.
  • 6Sakka V, Tsiodras S, Galani L, et al. Risk-factors and predictors of mortality in patients colonised with vancomycinresistant enterococci [J]. Clin Microbiol Infect, 2008,14 (1): 14-21.
  • 7Gegia M, Mdivani N, Mendes RE, et al. Prevalence of and molecular basis for tuberculosis drug resistance in the Republic of Georgia: validation of a QIAplex system for detection of drug resistance-related mutations [J]. Antimicrob Agents Chemother, 2008,52(2):725-729.
  • 8Maibach RC, Altwegg M. Cloning and sequencing an unknown gene of Tropheryma whipplei and development of two LightCycler PCR assays[J]. Diagn Microbiol Infect Dis, 2003, 46(3):181-187.
  • 9Anjum MF, Mafura M, Slickers P, et al. Pathotyping Escherichia coli by using miniaturized DNA microarrays [J]. Appl Environ Microbiol, 2007,73(17):5692-5697.
  • 10Aragon LM, Navarro F, Heiser V, et al. Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays[J]. J Antimicrob Chemother, 2006,57(5):825-831.

同被引文献57

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部